Login
Navigate Fool.com
Will SCMP beat
the market?
Community Rating: 3 Stars: Appealing

6.77 -0.19 (-2.73%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.96
Previous Close $6.96
Daily Range $6.62 - $6.96
52-Week Range $5.40 - $11.00
Market Cap $297.9M
P/E Ratio 45.13
Dividend (Yield) $0.00 (0.0%)
Volume 153,628
Average Daily Volume 215,566
Current FY EPS $0.52

How do you think SCMP
will perform against the market?

Top SCMP Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted August 11, 2011

I recently did OK on a short-term outperform of Sucampo, and jumped out before the stock turned back south. The stock has dropped moderately after the earnings PR today but I don't see the cause for c … More

0 Replies Reply Report this Post
 

drugncover (< 20)
Submitted October 5, 2007

Talk about inside dealing... reading the prospectus of this company is like wading through a swamp. They hold certain rights to all their compounds in a separate company, that the CEO of this company … More

2 Replies Reply Report this Post

News & Commentary

Why Sucampo Pharmaceuticals, Inc. Shares Jumped

Sucampo shares are off to the races after topping Wall Street's profit expectations in the fourth-quarter. Is this earnings beat meaningful or just white noise?

Why Sucampo Pharmaceuticals, Inc. Shares Popped

Sucampo's 8-K filing with the SEC delivers a nice surprise to shareholders.

Synergy Pharma Seeks to Treat Gastral Disorders And Diseases

Sector Update: Healthcare Shares Flat; Pluristem Therapeutics up 4% on Partnership with CHA Bio & Di

Sector Update: Healthcare Shares Flat; Pluristem Therapeutics up 4% on Partnership with CHA Bio & Diostech

Sector Update: Healthcare

Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, ...

Sector Update: Healthcare Shares Flat; Agenus up 10% on Malaria Vaccine Data

Sector Update: Healthcare

A One of a Kind Flagship Drug for Your Irritable Bowel

Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone)

See More SCMP News...

Sector

Healthcare

Industry

Drugs

SUCAMPO PHARMACEUTICALS, INC. (SCMP) Description

An emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Website: http://www.sucampo.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks